|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
24 October 2016 |
|
Main ID: |
NCT02931773 |
|
Date of registration:
|
29/09/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Autonomic Cardiovascular Neuropathy in Recently Diagnosed DM2 Patients (ACNDM2)
ACNDM2 |
|
Scientific title:
|
Autonomic Cardiovascular Neuropathy in Recently Diagnosed DM2 Patients and in Pre-Diabetes Patients |
|
Date of first enrolment:
|
August 2016 |
|
Target sample size:
|
60 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT02931773 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case Control, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Mexico
| | | | | | | |
|
Contacts
|
|
Name:
|
Manuel A Sierra-Beltrán, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Instituto Nacional De Cardiología "Ignacio Chávez" |
|
|
Name:
|
Manuel A Sierra-Beltrán, MD |
|
Address:
|
|
|
Telephone:
|
00525556557059 |
|
Email:
|
manuel.sierra-beltran96@alumni.imperial.ac.uk |
|
Affiliation:
|
|
|
|
Name:
|
Manuel A Sierra-Beltrán, Dr |
|
Address:
|
|
|
Telephone:
|
00525556557059 |
|
Email:
|
manuel.sierra-beltran96@alumni.imperial.ac.uk |
|
Affiliation:
|
|
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- patients who have not suffered Hypertension, Parkinson Diseae, Parkinsonic Syndrome,
Guillain-Barré Disease, Myocardial Infarction, Obesity nor Ischemic Stroke
Exclusion Criteria:
- Those older than 55 years old, or younger than 18 years old.
- Those who have suffered Hypertension, Parkinson Diseae, Parkinsonic Syndrome,
Guillain-Barré Disease, Myocardial Infarction, Obesity or Ischemic Stroke
Age minimum:
18 Years
Age maximum:
55 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Dysautonomia
|
|
Intervention(s)
|
|
Device: Task Force® Monitor
|
|
Primary Outcome(s)
|
|
Sympathetic hyperactivity in recently diagnosed DM2 patients
[Time Frame: one year]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|